Necrotizing enterocolitis (NEC) is an inflammatory intestinal disorder that affects 2%-5% of all premature infants. Enterobacter sakazakii, a common contaminant of milk-based powdered infant formula, has been implicated as a causative agent of sepsis, meningitis, and NEC in newborn infants, with high mortality rates. However, the role played by E. sakazakii in the pathogenesis of NEC is, to date, not known. Here, we demonstrate for the first time that E. sakazakii can induce clinical and histological NEC in newborn rats. E. sakazakii was found to bind to enterocytes in rat pups at the tips of villi and to intestinal epithelial cells (IEC-6) in culture, with no significant invasion. Exposure to E. sakazakii induced apoptosis and increased the production of interleukin-6 in IEC-6 cells and in the animal model. These data suggest that E. sakazakii could be a potential pathogen that induces NEC and triggers intestinal disease by modulating enterocyte intracellular signaling pathways.
Enterobacter sakazakii is an important emerging neonatal pathogen that is associated with outbreaks of meningitis, sepsis, and necrotizing enterocolitis (NEC) [1] . E. sakazakii is prevalent in certain milk-based powdered infant formulas, cereals, chocolate, potato flour, and pasta [2] [3] [4] . The number of E. sakazakii-related infections has substantially increased during the past 10 years owing to the increased use of infant formula. The US Food and Drug Administration has issued several warnings regarding E. sakazakii infection in newborns.
NEC is an inflammatory intestinal disorder that affects 2%-5% of all premature infants and is associated with high mortality rates. Three principal factors have been implicated in the pathogenesis of the disease: an immature intestinal epithelial barrier, abnormal bacterial colonization, and formula feeding. Although a variety of bacterial species have been implicated in the development of NEC, including Enterobacter, Clostridium, and Staphylococcus species, no single pathogen has yet been shown to cause the disease [5] . Enterobacter species have been associated with NEC and isolated from the blood, skin, cerebrospinal fluid, peritoneal fluid, urine, and respiratory tracts of affected infants [6, 7] . Milkbased infant formulas contaminated with E. sakazakii have been implicated in outbreaks of NEC, suggesting that this pathogen may be important for disease pathogenesis.
The establishment of disease depends on successful pathogen colonization and the ability of a microbe to adhere to host surfaces, such as the intestinal epithelial layer [8] . E. sakazakii adheres to endothelial cells and to neoplastic epithelial cell lines [9] . However, the associations between E. sakazakii and nontransformed intestinal epithelial cell lines remain poorly understood. Pathogen binding may trigger a number of different host responses, ranging from alteration in intracellular signaling pathways, chemokine and cytokine release, and induction of apoptosis. A variety of inflammatory molecules, including tumor necrosis factor (TNF)-␣, nitric oxide, and interleukin (IL)-6, have been implicated in the pathogenesis of NEC [10] . In particular, elevated levels of IL-6 have been found in blood and stool samples of infants with NEC [11] . Apoptosis is a programmed cell death, which under homeostatic conditions exists in harmony with cellular mitosis. Experimental NEC is associated with increased enterocyte apoptosis [12] . We therefore hypothesized that colonization of the intestine by E. sakazakii may contribute to the pathogenesis of NEC by stimulating the release of inflammatory factors and inducing the apoptosis of enterocytes. The present study examined the causative relationship between E. sakazakii and NEC in a rat model of the disease.
METHODS
Bacterial strains, cells, and reagents. E. sakazakii (strain 51329), Escherichia coli DH5-␣, and rat intestinal epithelial cells (IEC-6; passages 20 -26) were obtained from the American Type Culture Collection. IEC-6 cells were maintained in Dulbecco's modified Eagle medium supplemented with 10% fetal calf serum, 1 U/mL insulin, 100 U/mL penicillin G, and 100 U/L streptomycin. Rodent formula (Esbilac) was obtained from PetAg.
Transformation of E. sakazakii with green fluorescent protein (GFP) plasmid. E. sakazakii were grown for 8 h in Luria broth at 37°C, centrifuged to pellet down bacteria, washed, and treated with 0.1 mol/L calcium chloride for 30 min on ice. Then, E. sakazakii were transformed with a GFP plasmid, as described elsewhere [13] . Colonies were assessed for GFP expression by viewing them under ultraviolet light, and further cultures were grown from a single colony.
E. sakazakii infection experiments using the rat model of NEC. Animal experiments were approved by the Institutional Animal Care and Use and Biosafety Committees of Childrens Hospital Los Angeles. NEC was induced in newborn rats by formula feeding and hypoxia [14] . Briefly, timed-pregnant rats were purchased from Harlan, and labor was induced with oxytocin at term. Six experimental groups were used. One group received 0.2 mL of clean Esbilac formula twice daily (the formula feeding [FF] group); a second group received the same feeding protocol as the FF group and thrice-daily hypoxia exposure (ϳ5 min each) with 5% O 2 and 95% N 2. (the FFϩH group); a third group received 0.2 mL of clean Esbilac formula once daily and 0.2 mL of formula containing a known quantity of E. sakazakii once daily (the FFϩES group); a fourth group received the same feeding protocol as the FFϩH group and thrice-daily hypoxia exposure (the FFϩHϩES group); and a fifth and a sixth group received the same protocols as the FFϩES and the FFϩHϩES group, except that E. sakazakii was replaced with E. coli (the FFϩEC group and the FFϩHϩEC group, respectively). NEC was graded microscopically by a pathologist blinded to the groups, from grade 0 (normal) to 4 (severe) on the basis of pathological manifestations, including submucosal edema, epithelial sloughing or obliteration, neutrophil infiltration, intestinal perforation, and necrosis [14] .
Binding and invasion assays using IEC-6 cells. Various doses (1 ϫ 10 4 -1 ϫ 10 7 cfu/well) of E. sakazakii were added to confluent monolayers of IEC-6 cells separately and incubated for 2-12 h. Medium was changed every 1 h (after 2-h incubation) to limit bacterial multiplication. The cells were washed with Hank's balanced salt solution. Monolayers were solubilized with 0.1% Triton X-100 for 8 min. The contents were removed, diluted serially, plated onto blood agar, and incubated at 37°C overnight. The number of bacterial colonies was recorded, and the percentage of binding was calculated on the basis of inocu- Figure 1 . Inducement of increased intestinal injury by Enterobacter sakazakii in the rat model of necrotizing enterocolitis. Panel A compares a rat pup from the FFϩHϩES (formula feeding, hypoxia exposure, and E. sakazakii ) group (left) with one from the FFϩH (formula feeding and hypoxia exposure) group (right). The FFϩHϩES-treated rat demonstrates increased abdominal girth, abdominal wall discoloration, and evidence of clinical peritonitis. The FFϩH-treated rat is not distended, and only a milk spot is visible through a normal abdominal wall. Panels B and C demonstrate the gross intestinal morphological appearance after 4 days of FFϩHϩES treatment. The intestine has patchy necrosis, with evidence of hemorrhagic intestine and pneumatosis intestinalis. Panel D shows the control rat pup, which has a normal-appearing intestine without necrosis, and only stool is visible within the lumen. lum size. To determine the invasion of E. sakazakii into IEC-6 cells, the experiments were performed as described for binding, except that the cells were incubated with gentamicin (75 g/mL)
for 60 min after completion of the initial incubation, to kill extracellular bacteria.
Cytokine profiling after exposure to E. sakazakii. IEC-6 cells were grown to confluence and incubated with E. sakazakii (1 ϫ 10 7 cfu/well) for 1-6 h. The experimental medium and bacteria were collected and spun twice at 3000 rpm for 10 min to collect the supernatants. Cytokine concentrations in various samples were measured by the Luminex assay [15] . Total RNA was extracted from the infected cells by means of the RNeasy Kit (Qiagen). Reverse-transcription polymerase chain reaction (RT-PCR) for IL-6 was performed using equal amounts of cDNA for 30 cycles, with forward primer 5'-GATGTTGTTGACAGCC-ACTGCCTT-3' and reverse primer 5'-TTGGATGGTCTTG-GTCCTTAGCCA-3'.
Evaluation of apoptosis in vitro and of intestine in rat pups after E. sakazakii exposure. IEC-6 cells, grown to 90% confluence in 4-well chamber slides, were infected for varied periods with E. sakazakii, washed, and fixed with 1% paraformaldehyde. The cells were then stained using the ApopTag Red In Situ Apoptosis Detection Kit (Chemicon) along with 4',6-diamidino-2-phenylindole (DAPI) and were visualized using a fluorescent microscope. Additionally, apoptosis of IEC-6 cells infected with E. sakazakii was assessed using a carboxyfluorescein caspase-3 detection kit (ApoLogix). The number of apoptotic cells per high-powered field were determined by fluorescent microscopy. Intestinal segments were obtained, placed in 1% paraformaldehyde, and embedded in paraffin. Cryosections were also obtained and stained with DAPI. Immunofluorescent microscopy was used to assess the association of GFP-labeled E. sakazakii with the intestinal epithelial layer. Apoptosis was assessed after staining both paraffin sections and cryosections with ApopTag Red stain.
Assessment of intestinal damage by electron microscopy. Segments of small intestine were obtained from rat pups subjected to FFϩH or FFϩHϩES and washed 3 times in 0.1 mol/L cacodylate buffer for 15 min each. The intestinal lumen was exposed, postfixed with 2% osmium tetroxide in 0.1 mol/L cacodylate buffer at 4°C for 1 h, and processed for scanning electron microscopy (SEM). The images were captured using an FEI Quanta 200 ESEM microscope under low vacuum conditions. Statistical analysis. Where appropriate, Mann-Whitney U analysis or Student's t test was performed. Differences were considered significant at P р .05.
RESULTS
Effect of E. sakazakii on NEC in a rat model. Previous experiments at our laboratory established a reproducible rat model of NEC [10] . In this model, the combination of formula feeding and hypoxia leads to macroscopic and microscopic intestinal inflammation, similar to that seen in human NEC. Findings include segmental small-bowel necrosis, edema, neutrophil infil- Figure 2 . Histological findings in the intestines of rat pups treated or not treated with Enterobacter sakazakii. The shown paraffin-embedded intestine sections from rats in each group are representative sections from several experiments. The sections were stained with hematoxylineosin on day 4. Panel A shows the preserved architecture of villi after 4 days of formula feeding (FF) only. Panel B reveals neutrophils in the villus tip (arrow) and alteration of villus structure in the FFϩES (formula feeding and E. sakazakii ) group. Panel C demonstrates the villus tip sloughing and villus blunting seen in a rat pup in the FFϩH (formula feeding and hypoxia exposure) group after 4 days. Panel D demonstrates the greatest degree of derrangement seen, with luminal neutrophils, loss of normal villus architecture, and sloughing, in rat pups in the FFϩHϩES (formula feeding, hypoxia exposure, and E. sakazakii ) group. Panel E shows the preserved architecture in a rat pup in the FFϩEC (formula feeding and Escherichia coli ) group, whereas panel F demonstrates only mild goblet cell hyperplasia in the FFϩHϩEC (formula feeding, hypoxia exposure, and E. coli ) group. Panel G shows histological scoring of intestine sections; differences were statistically significant between the FFϩH and FFϩHϩES groups (*P ϭ .020) and the FF and FFϩHϩES groups (*P ϭ .027).
tration, epithelial sloughing, and intestinal perforation or sepsis [16] . Because E. sakazakii has been implicated as a potential pathogen in human NEC, we investigated whether it was capable of increasing disease severity in the rat model. A laboratory E. coli strain, DH5-␣, was used as a control. The appropriate dose of E. sakazakii was determined by measuring mortality rates in pups fed formula containing 1 ϫ 10 3 , 1 ϫ 10 5 , and 1 ϫ 10 7 cfu/dose. Formula containing 1 ϫ 10 3 cfu/dose together with hypoxia did not increase disease severity significantly compared with that in controls, whereas 1 ϫ 10 7 cfu/dose conferred Ͼ95% mortality in rat pups by experimental day 4 (data not shown). However, 1 ϫ 10 5 cfu/dose added to formula produced clinical symptoms consistent with grade 3 NEC in the rat pup model by day 4 (figure 1A) . Rat pups subjected to FFϩHϩES had marked abdominal distention and abdominal wall discoloration, compared with those subjected to FFϩH ( figure 1A-1D ). Abdominal discoloration and distention are commonly found in severe human disease. The animals in the FFϩH group had a mortality rate of 40%, compared with 70% for those in the FFϩHϩES group. Rat pups in the control groups (those subjected to FFϩEC or FFϩHϩEC) did not have a higher mortality rate than those in the FF and FFϩH groups (findings similar to those shown in figure 1D ). Furthermore, all pups treated with E. sakazakii had bacteremia at the completion of the experiment, suggesting systemic disease and loss of intestinal barrier integrity, whereas no bacteremia was detected in the groups not fed E. sakazakii or E. coli (data not shown).
Histological examination of intestine from day 4 in control pups (the FF group) revealed intact villus architecture (figure 2A), whereas villus tip sloughing and blunting was observed in both the FFϩH and FFϩES groups ( figure 2B and 2C ). In contrast, histological grading of pups in the FFϩHϩES group revealed more intestinal injury and inflammation than in the FFϩH group (P ϭ .02) ( figure 2D ). Pups subjected to FFϩHϩEC or FFϩEC showed no significant intestinal damage compared with controls ( figure 2E and 2F) . Although supplementation with E. sakazakii increased intestinal injury, no significant difference was observed with E. sakazakii feeding alone (P ϭ .078 for the comparison with FFϩH) (figure 2G). Rat pups fed E. coli had no significant increase in pathological score relative to baseline. E. sakazakii-treated groups had more cellular infiltrates, demonstrated by more neutrophils within the body of the villus and epithelial sloughing.
SEM of intestine in E. sakazakii-treated rat pups. SEM was performed to observe more closely the morphological changes in villus architecture after E. sakazakii infection. As shown in figure 3A and 3B, intestines of rats in the FFϩH group showed intact villi, without a significant number of attached bacteria. In contrast, feeding E. sakazakii to rat pups greatly increased intestinal injury and villus disruption ( figure 3D) . A large number of bacteria were attached to the infected villi, with enterocyte blebbing and formation of gaps in the epithelium ( figure 3C and 3E ). Higher-magnification photographs showed that bacteria were present at the site of bleb rupture (figure 3F), suggesting that E. sakazakii directly damages the epithelial cells of villus tips.
E. sakazakii adherence to IEC-6 cells in vitro and to enterocytes in newborn rats. The infection of rat pups showed that E. sakazakii interacts with and damages intestinal epithelial cells, which could be responsible for the onset of NEC. To understand the mechanisms involved in E. sakazakii-induced intestinal epithelial cell damage, we developed an in vitro model of E. sakazakii infection using IEC-6 cells in culture. Initially, we determined the effect of inoculum size on E. sakazakii binding to IEC-6 cells after 2 h of infection. E. sakazakii bound to IEC-6 cells at a frequency of 0.5% at an inoculum of 1 ϫ 10 4 cfu/well, Figure 3 . Scanning electron microscopy (SEM) of rat intestine with or without Enterobacter sakazakii infection. Rat pups were subjected to formula feeding and hypoxia exposure without (A and B ) or with E. sakazakii (C-F), as described in Methods. Small pieces of intestinal samples were prepared for SEM. Bacteria are indicated by arrows.
Original magnifications are as follows: ϳϫ300 (A), ϫ3400 (B), ϫ5000 (C), ϫ580 (D), ϫ3200 (E), and ϫ9600 (F).
and the frequency increased to 2.5% when 1 ϫ 10 7 cfu/well were added (figure 4A). Subsequent increases in inoculum sizes did not result in greater binding.
Of note, the degree of invasion of E. sakazakii into IEC-6 cells was very low (frequency of 0.01%), suggesting that E. sakazakii could not efficiently invade intestinal epithelial cells. Because we observed optimal binding and invasion with 1 ϫ 10 7 cfu/well, time course experiments were performed with 1 ϫ 10 7 cfu/well over a period of 6 h. As shown in figure 4B , the binding of E. sakazakii to IEC-6 cells increased significantly (4-fold) at 6 h compared with 2 h after infection, reaching a plateau after 6 h. However, the invasion was increased only 2-fold (0.01% at 2 h vs. 0.02% at 6 h). Light microscopic analysis of E. sakazakii binding to IEC-6 cells revealed that the bacteria bound diffusively to enterocytes, a pattern similar to that seen with SEM ( figure 4C ). To examine whether E. sakazakii binds to enterocytes in vivo, we examined cryosections of intestine obtained from rat pups that had been fed GFP-labeled E. sakazakii. The sections were stained with DAPI to enable viewing of villus structure. GFP-labeled E. sakazakii was seen mainly on the villus surface in FFϩHϩES-treated rats ( figure 4C) . Interestingly, the association was seen only in the distal small intestine and not in the proximal areas, suggesting that specific receptors for E. sakazakii binding may be expressed in the distal small intestine. Notably, the distal small intestine is the intestinal region most frequently affected in both human and experimental NEC [14] .
Induction of apoptosis by E. sakazakii in IEC-6 cells and enterocytes in newborn rats. SEM experiments demonstrated that administration of E. sakazakii causes damage to the tips of villi, suggesting that the bacterium might kill the cells to which it attaches. To examine whether interaction between E. sakazakii and IEC-6 cells induces apoptosis, IEC-6 cells were stained with ApopTag stain after incubation of the cells with 1 ϫ 10 7 cfu/well for 0 -12 h. This method identifies apoptotic cells by staining fragmented DNA, which appears during the late stage of apoptosis. The number of apoptotic IEC-6 cells increased with increasing time of E. sakazakii infection (figure 5A). Caspase-3 activation, an early marker of apoptosis, was also examined. Quantification of apoptotic cells suggested that the increase in apoptosis reached statistical significance by 4 h and appeared to plateau at 6 h after infection, when 70% of IEC-6 cells demonstrated signs of apoptosis (P Ͻ .001) (figure 5B). Furthermore, staining of GFP-labeled E. sakazakii-infected hypoxic intestinal segments with ApopTag stain revealed more apoptosis in enterocytes than in controls ( figure 5C ). In the control sample, apoptosis was seen mainly at the villus tip, but with E. sakazakii infection it was everywhere in the villus epithelium. Apoptotic changes were almost entirely absent in the FF group (data not shown). These results indicate that E. sakazakii induces apoptosis in intestinal epithelial cells, both in vitro and in vivo.
Induction of a proinflammatory cytokine response by E. sakazakii in intestinal epithelial cells. Cytokines activate local and systemic inflammatory responses that may contribute to the pathogenesis of NEC. It is possible that E. sakazakii increases NEC by stimulating epithelial inflammatory cytokine expression. To examine the production of cytokines in intestinal epithelial cells, we collected supernatants from IEC-6 cells treated with E. sakazakii and assayed for cytokine production. Exposure to E. sakazakii leads to a time-dependent increase in IL-6 production after 2 h of infection, compared with that in FFϩH-treated controls (P ϭ .018) (figure 6A). Of note, IL-1␣ was also detected after 2 h of infection; however, there was no apparent Total cell-associated bacteria (binding) or total intracellular bacteria (invasion) were determined as described in Methods. The experiments were performed at least 5 times, and the data are shown as mean Ϯ SD values expressed as either relative binding or invasion, with the results after 6 h of treatment or with a 1 ϫ 10 7 cfu/well inoculum of E. sakazakii considered to be 100%. In some experiments, E. sakazakii -infected IEC-6 cells were stained with 4',6-diamidino-2-phenylindole (DAPI), and bacteria were observed by means of transmitted light. Similarly, rat pups were infected with green fluorescent protein-labeled E. sakazakii to establish in vivo epithelial association of E. sakazakii. Cryosections of intestines were stained with DAPI and examined with a fluorescence microscope (C).
correlation with E. sakazakii dose (data not shown). Other cytokines, including interferon-␥, TNF-␣, IL-2, IL-4, IL-10, and IL-12, were also assayed, but levels were not detectable.
IL-6 production reached maximal levels within 12 h after infection. In addition, expression of IL-6 was also determined at the mRNA level by RT-PCR. E. sakazakii-treated IEC-6 cells showed elevated levels of IL-6 mRNA expression after 60 min (figure 6B). RPS-17, which was used as a control, showed no significant differences between various time points. We further assessed whether E. sakazakii induces IL-6 production in neonatal rats. The animals were subjected to FFϩHϩES, and serum samples were collected to evaluate IL-6 levels. In agreement with the IEC-6 cell data, rat pups that received FFϩHϩES had higher levels of IL-6 after 4 days of treatment than did those subjected to FFϩH treatment alone ( figure 6C ). Taken together, these data suggest that IL-6 may be an important inducible cytokine in the pathogenesis of E. sakazakii-induced NEC. Figure 6 . Expression of interleukin (IL)-6 in IEC-6 cells and in rat pups infected with Enterobacter sakazakii. Confluent monolayers of IEC-6 cells were infected with E. sakazakii for varying periods, and the cytokines present in the supernatants were determined by Luminex assay (A). Results are representative of 3 independent experiments performed in triplicate (*P Ͻ .05). Total RNA was extracted from the cells, and reverse-transcription polymerase chain reaction was performed for 30 cycles on normalized cDNA, using IL-6 -specific primers (B). RPS-17 primers were used as internal controls. In addition, serum samples were collected on day 4 from rat pups subjected to various treatments, and IL-6 production was determined by Luminex assay (C). The production of IL-6 in rat pups in the FFϩESϩH (formula feeding, E. sakazakii, and hypoxia exposure) group was significantly greater than in controls. FFϩH, formula feeding and hypoxia exposure. *P Ͻ .05 and **P Ͻ .001. Figure 5 . Induction of apoptosis in intestinal epithelial cells by Enterobacter sakazakii. IEC-6 cells were grown to 90% confluence in 8-well chamber slides and incubated with E. sakazakii for varying periods. Cells were washed, fixed, treated with TUNEL red reagent, and viewed under a fluorescence microscope (A). In separate experiments, infected cells were washed, released from plates with medium containing ethylene glycol tetraacetic acid/1% bovine serum albumin, and stained using the TUNEL red kit, and apoptotic cells were counted (B) (*P Ͻ .001). In addition, cryosections of intestines from rat pups in the FFϩH (formula feeding and hypoxia exposure) group (left) or the FFϩHϩES (formula feeding, hypoxia exposure, and E. sakazakii ) group (right) were stained with 4',6-diamidino-2-phenylindole and ApopTag stain (C). 
DISCUSSION
Although bacterial colonization is broadly regarded as a key step in the pathogenesis of NEC, there is a paucity of information regarding the roles of individual bacterial species. Several reports have suggested that NEC may be associated with E. sakazakii, a common contaminant of infant formula [1, 17, 18] . Here, we have demonstrated for the first time that E. sakazakii can induce the clinical and morphological changes of NEC in a rat pup model. Infection with E. sakazakii was confirmed in all surviving rat pups, as evidenced by the presence of GFP-labeled E. sakazakii within the intestine and in cultures of the intestinal contents of pups fed E. sakazakii (data not shown). The enhanced pathogenesis caused by E. sakazakii in the compromised intestine has particular relevance to newborn infants in whom NEC develops. Premature infants exhibit a relative intestinal immune deficiency, including decreased production of local antibacterial products [19] , decreased levels of immunoglobulin (such as IgA) [20] , and altered immune cell production [21] , all of which may contribute to a compromised intestinal epithelial layer. In addition, a subgroup of newborn infants at increased risk for NEC have underlying congenital defects, such as pulmonary or cardiac anomalies [22] . These defects may result in global hypoxia and thus lead to intestinal hypoxia. Intestinal epithelial hypoxia has been shown elsewhere to diminish epithelial barrier integrity, increase intestinal permeability, and allow for increased bacterial translocation [23] . Therefore, in accordance with our animal findings, the effects of E. sakazakii may be especially enhanced in premature or hypoxic newborns.
A primary function of the intestine is to protect the internal environment from the external world, and regulation of enterocyte apoptosis is crucial to healthy maintenance of the gut barrier [24] . In fact, enterocytes are among the most rapidly proliferating cells in the body, and mitotic activity is matched by apoptosis, to maintain normal form and function. Dysregulated enterocyte apoptosis has been associated with several intestinal disorders [25] . Moreover, certain pathogens can increase epithelial apoptosis, thereby contributing to disease pathogenesis [26] . However, an imbalance between normal rates of apoptosis and restitution may reduce barrier integrity, allowing for bacterial translocation and the development of systemic sepsis. In agreement with this concept, our experiments demonstrate that E. sakazakii induces significant apoptosis in IEC-6 cells in vitro and in an animal model of NEC, particularly in combination with hypoxia. In contrast, nonpathogenic E. coli did not increase disease severity, indicating that some specific traits of E. sakazakii are responsible for the pathogenesis of NEC.
Although we did not specifically address the impact of enterocyte apoptosis on intestinal barrier integrity, other investigators have clearly documented a direct relationship between increased enterocyte apoptosis and the loss of barrier integrity [24] . Our SEM experiments revealed intestinal epithelial disarray, blebbing, and holes in the intestinal mucosa in FFϩHϩES-treated rat pups, suggesting a necrotic pattern. Therefore, the induction of apoptosis in NEC by bacterial insult or by local inflammatory cytokines may progress to necrosis after prolonged infection, resulting in loss of intestinal barrier integrity. Furthermore, all rat pups subjected to FFϩHϩES treatment developed bacteremia after 4 days, suggesting that intestinal translocation of bacteria occurred [27] . Some pathogens are able to enter the systemic circulation through direct invasion of the intestinal epithelium [28] . However, the absence of invasion in our in vitro experiments leads us to speculate that E. sakazakii induces intestinal damage by binding to the external surface of enterocytes and inducing apoptosis or necrosis. However, the precise mechanisms of the interaction between E. sakazakii and intestinal epithelial cells require further elucidation.
Pathogen-associated molecular pattern molecules, including lipopolysaccharide (LPS), lipoproteins, glycolipids, peptidoglycans, fatty acids, and nucleic acids of bacteria, often interact with various pattern-recognition receptors known as Toll-like receptors (TLRs) [29] . Different TLR family members have been identified and are expressed in a variety of cell types, including macrophages, dendritic cells, and enterocytes [30] . Because LPS is an outer membrane virulence factor of E. sakazakii, it is possible that E. sakazakii interacts with enterocytes through LPSmediated binding to TLR4. Previous experiments have demonstrated that LPS facilitates bacterial attachment to Caco-2 cells and increases bacterial translocation [31] . Similarly, we have demonstrated previously that IEC-6 cells express TLR4 [32] . TLR expression may vary with intestinal location and postnatal maturation, thereby providing more opportunity for E. sakazakii to bind to certain portions of the intestine and alter the host's response to commensal or pathogenic microorganisms. Indeed, in mouse models of colitis and NEC, TLR4 knockout mice have reduced inflammatory infiltrates, compared with that in wildtype mice [33] . Studies are in progress to identify the importance of TLRs in intestinal epithelial cell injury caused by E. sakazakii.
Alterations in cytokine production, including elevated levels of IL-6, have been associated with human NEC and may be useful clinical markers of disease severity [11, 34, 35] . Our experiments revealed that IL-6 expression and production were elevated in intestinal epithelial cell cultures after exposure to E. sakazakii. Increased levels of IL-6 were found in the serum of rat pups after E. sakazakii formula feeding; however, the role played by IL-6 in E. sakazakii-associated pathogenesis remains to be defined. Thus, the capability of E. sakazakii to trigger apoptosis and initiate a proinflammatory response may be fundamental to the pathogenesis of E. sakazakii-induced NEC.
In summary, oral administration of E. sakazakii increases epithelial injury in experimental NEC. Our findings support the notion that E. sakazakii might be a potential pathogen associated with human NEC. Furthermore, E. sakazakii likely elicits epithelial damage through enterocyte association without direct inva-sion. E. sakazakii may cause barrier damage by inducing enterocyte apoptosis and stimulating expression of the inflammatory cytokine IL-6. Further understanding of the role played by E. sakazakii in the pathogenesis of NEC may provide clues for developing new therapeutic strategies against this disease.
